NAD+ vs NMN
NAD+ is the whole molecule — the cellular cofactor every sirtuin and PARP needs. NMN (nicotinamide mononucleotide) is the direct biosynthetic precursor, one step upstream of NAD+. Oral NAD+ is poorly absorbed; injectable NAD+ bypasses the gut. Oral NMN is reasonably absorbed and converts to NAD+ intracellularly. Both pathways elevate intracellular NAD+ — the tradeoff is delivery practicality.
If the research question is systemic NAD+ elevation fast, injectable NAD+ is the more direct tool — bioavailability and tissue distribution are well characterized. If the question is oral daily precursor supplementation, NMN is the cleaner oral option with reliable cellular uptake. Both end at the same intracellular NAD+ pool, but by very different routes.
Contender A
NAD+
The cofactor itself — drives sirtuin activity, PARP function, mitochondrial NADH cycling, and cellular energy production. Delivered via IV or SubQ injection for systemic elevation.
- Half-life
- ~2-6 hours intravenously
- Primary use
- Rapid systemic NAD+ elevation research
- Dose range
- 100-1000 mg IV or SubQ, varied cadence
- Cost tier
- $$$ · High sourcing cost
Contender B
NMN
Nicotinamide mononucleotide — direct NAD+ precursor. Oral NMN enters cells via Slc12a8 transporter (debated) and direct biosynthetic conversion, ultimately elevating intracellular NAD+.
- Half-life
- ~30 min plasma, cellular effect longer
- Primary use
- Oral precursor supplementation research
- Dose range
- 250-1000 mg oral daily
- Cost tier
- $$ · Moderate sourcing cost
Detailed Comparison
10 attributes side-by-side. Highlighted rows show where one tool has a clear structural edge.
| Attribute | NAD+ | NMN | Edge |
|---|---|---|---|
Molecule type | Whole cofactor | Direct precursor | Tie |
Primary delivery route Oral convenience is why NMN dominates daily-supplementation protocols. | IV / SubQ / intranasal | Oral / SubQ | B |
Cost per equivalent NAD+ elevation | Higher | Lower | B |
Speed of elevation | Hours (IV) | Days-to-weeks (oral) | A |
Tissue distribution | Well characterized | Cellular uptake mechanism debated | A |
Protocol complexity | IV or injection setup | Oral capsule | B |
Evidence depth for anti-aging endpoints | Preclinical + practitioner | Preclinical + small human trials | B |
Subjective energy response | Acute (post-IV) | Gradual | Tie |
Flushing / GI side effects | Rare | Rare at research doses | Tie |
Pairs with | SS-31, MOTS-c, resveratrol | Same | Tie |
Practitioner Notes
Sourced from practitioner-validated protocols — not PubMed abstracts.
The usual way this debate gets framed online — 'NAD+ vs NMN, which is better' — misses the actual research question. Both endpoints elevate intracellular NAD+, which is what matters for sirtuin and PARP activity. The real decision is delivery: can the protocol accept IV infusions or SubQ injections, or does it need oral-daily practicality?
Protocols in the corpus typically use both. NMN oral daily as the baseline NAD+ precursor supplementation, with periodic NAD+ IV (monthly to quarterly) for rapid-saturation pulses. The IV delivers a peak intracellular NAD+ level that oral NMN can't match in a reasonable timeframe; the daily NMN holds a steady-state floor.
On the NMN cellular-uptake question: the Slc12a8 transporter debate is real but mostly academic — even if NMN only enters cells via extracellular conversion to NR then re-conversion, the end result is intracellular NAD+ elevation, and that's what protocols measure.
Injectable NMN (SubQ, not oral) is emerging in practitioner protocols as a middle ground — faster than oral, less expensive than IV NAD+. Evidence is thin but growing.
Stacking & Switching
Can these be combined? Should you switch from one to the other? Titration considerations.
Stack compatibility: See the “Stacks well” or “Stack compatibility” row in the comparison table above. When the edge column shows Tie, both compounds run together cleanly. When one compound dominates, check the protocol notes for the specific stacking pattern practitioners use.
Switching protocol: The general pattern across practitioner protocols: hold the current dose stable, introduce the new compound at its lowest titration step, run both for a 1-2 week cross-over window, then taper the original. Abrupt switches produce rebound effects as the original compound's steady state clears.
Half-life math: DoseCraft's PK-aware AI models half-life decay and stack overlap across every pairing above. The 20x20 interaction matrix flags contraindications automatically — no manual math, no overlapping-signal blindspots.
Frequently Asked Questions
Indexed for SERP FAQPage rich results.
Which raises NAD+ levels more?
+
IV NAD+ delivers a higher acute peak. Daily oral NMN delivers a more sustained elevation. Over a month, the integrated NAD+ exposure from each is roughly comparable at research doses.
Does oral NAD+ work?
+
Poorly. NAD+ is degraded in the GI tract and absorption is limited. This is why injectable or intranasal NAD+ is the research-grade route, and oral supplementation uses precursors (NMN, NR) instead.
Is NMN better than NR (nicotinamide riboside)?
+
Open research question. NR is one step further upstream than NMN. Both elevate intracellular NAD+. Practitioner preference in our corpus leans NMN for the more direct biosynthetic path.
How long until I feel something?
+
Research subjects on IV NAD+ often report subjective energy response within hours. Oral NMN research reports gradual changes over 2-6 weeks of daily supplementation.
Can I stack with resveratrol or pterostilbene?
+
Yes — standard longevity stack pattern. Resveratrol and pterostilbene are sirtuin activators; NAD+ / NMN supply the cofactor. They work in the same pathway at different points.
Related Comparisons
Longevity
MOTS-c vs SS-31
MOTS-c is a mitochondrial-derived peptide that signals systemically — it activates AMPK, improves insulin sensitivity, and enhances exercise capacity. SS-31 (elamipretide) is a mitochondrial-targeting peptide that binds cardiolipin on the inner mitochondrial membrane, preserving electron-transport-chain function and reducing oxidative damage. Same organelle, completely different mechanism.
ReadLongevity
Epitalon vs Thymalin
Epitalon (also called Epithalon) is a synthetic tetrapeptide developed from pineal-gland extract. Thymalin is a polypeptide complex from thymus tissue. Both emerged from the Khavinson longevity research program in Soviet/Russian gerontology. Different organ sources, different mechanisms — pineal / circadian for Epitalon, thymic / immune for Thymalin.
ReadHealing
GHK-Cu vs Copper Tripeptide
GHK-Cu and 'copper tripeptide' are the same molecule: a glycyl-L-histidyl-L-lysine tripeptide bound to a copper-2 ion. The terminology overlap confuses newcomers. The meaningful research question isn't which molecule — it's topical vs injectable delivery, because the two routes produce very different biological profiles.
ReadTrack Your Protocol with PK-Aware AI
Compound choice is step one. DoseCraft models half-life decay, stack overlap, and titration paths across 90+ peptides — a pharmacokinetic reasoning layer on top of practitioner-validated protocols.
Track your protocol with PK-aware AI in DoseCraftResearch-only disclaimer: This comparison is for research and educational purposes only. Peptides referenced are sold for research use by third-party suppliers. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed physician before acting on any peptide protocol information.